Camelot Portfolios, LLC Astrazeneca PLC Transaction History

Camelot Portfolios, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $42,557 - $51,488	637 New	637 $49,000
Q2 2022 Jul 18, 2022	SELL	$59.26 - $71.14 $364,745 - $437,866	-6,155 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$55.72 - $67.12 $291,582 - $351,238	-5,233 Reduced 45.95%	6,155 $408,000
Q4 2021 Jan 04, 2022	BUY	$54.02 - $63.83 $213,919 - $252,766	3,960 Added 53.31%	11,388 $663,000
Q3 2021 Nov 04, 2021	BUY	$55.56 - $60.79 $412,699 - $451,548	7,428 New	7,428 $446,000

1,350

477M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.